The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Fall 2025 RFP: Data Advice To Action - DATA-PD, 2025Machine Leaning Based Proteomics Integration Reveals Biomarkers of Disease Pathology and Longitudinal Progression in PD and DLB
Study Rationale: Parkinson’s disease is usually diagnosed by symptoms, but the biological changes driving the disease begin many years earlier. While new tests that detect abnormal alpha-synuclein are...
-
Research Grant, 2025Brain Systems and Neurodegenerative Co-pathologies in Sleep Disturbance
Study Rationale: Sleep problems, like acting out dreams or waking up during sleep, can occur years before people are diagnosed with Alzheimer’s disease or Lewy Body diseases, such as Parkinson’s. Some...
-
Research Grant, 2025Standardization and Validation of Neuromelanin-Sensitive MRI Biomarkers for Disease Progression in Parkinson’s Disease Using PPMI Data
Study Rationale: Parkinson’s disease causes the loss of brain cells that make dopamine, a chemical needed for normal movement. These cells contain a natural pigment called neuromelanin, which fades as...
-
Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program, 2025Predicting Freezing of Gait in Parkinson’s Disease: An Objective Quantitative Exploration Combining Patient Perception with Multi-Dimensional Digital Gait Analysis & Multi-Domain Cognitive Testing
Study Rationale: Freezing of gait (FOG) is a debilitating – and not well understood - symptom impacting many patients with Parkinson’s disease (PwPD). FOG can occur during any stage of the disease but...
-
Spring 2025 RFA: Molecular MRI Biomarker Program, 2025Rapid and Quantitative Multi-metabolite Imaging in Parkinson’s Disease using AI Boosted Chemical Exchange Saturation Transfer Magnetic Resonance Fingerprinting (CEST MRF)
Study Rationale: Parkinson’s disease (PD) is often diagnosed when noticeable movement problems appear, but this happens later in the disease. There is a pressing need for new ways to detect early...
-
, 2025Harmonization of LRRK2 Parkinson’s Disease Cohorts
Study Rationale: LRRK2 variants are the most common cause of autosomal dominant Parkinson’s disease yet the natural history of LRRK2 Parkinson’s disease is not fully understood. While multiple LRRK2 P...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.